Identification of an oculomotor biomarker of preclinical Huntington disease
- PMID: 16625001
- DOI: 10.1212/01.wnl.0000218215.43328.88
Identification of an oculomotor biomarker of preclinical Huntington disease
Abstract
The authors examined oculomotor function to identify a biomarker of disease progression in genetically confirmed preclinical and early clinical Huntington disease (HD). Initiation deficits of voluntary-guided, but not reflexive, saccades were characteristic of preclinical HD. Saccadic slowing and delayed reflexive saccades were demonstrated in clinical but not preclinical HD. Saccadic measures provide biomarkers of disease progression in both preclinical and early clinical stages of HD.
Comment in
-
The eyes as a window into disease prevention.Neurology. 2006 Aug 8;67(3):376-7. doi: 10.1212/01.wnl.0000232764.18332.b6. Neurology. 2006. PMID: 16894093 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical